文献速递物质与行为成瘾

单次氯胺酮输注联合正念行为矫正治疗可卡因依赖:一项随机临床试验

A Single Ketamine Infusion Combined With Mindfulness-Based Behavioral Modification to Treat Cocaine Dependence: A Randomized Clinical Trial.
PubMed 文献 · Am J Psychiatry · 2019-06-24

氯胺酮组末两周戒断率48.2% vs 10.7%,复发风险降低53%(HR=0.47),渴求评分降低58.1%,差异均显著。

要点

  • 单次氯胺酮输注可提高可卡因依赖者末两周戒断率(48.2% vs 10.7%)。
  • 氯胺酮组复发风险显著降低53%(HR=0.47,95%CI 0.24-0.92)。
  • 氯胺酮组渴求评分较对照组低58.1%(95%CI 18.6-78.6)。

核心结论

  • 单次氯胺酮输注联合正念行为矫正可改善可卡因依赖成人的戒断、渴求和复发风险。

主要发现

  • 氯胺酮组末两周戒断率48.2%,咪达唑仑组10.7%(意向性分析)。
  • 氯胺酮组复发(使用或脱落)风险较咪达唑仑组降低53%(HR=0.47;95%CI=0.24, 0.92)。
  • 氯胺酮组整个试验期间渴求评分较咪达唑仑组低58.1%(95%CI=18.6, 78.6)。
  • 输注耐受良好,无参与者因不良事件退出研究。

临床怎么用

  • 对于可卡因依赖且接受正念行为矫正的成人,可考虑单次氯胺酮输注以促进戒断和降低复发风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Research has suggested that subanesthetic doses of ketamine may work to improve cocaine-related vulnerabilities and facilitate efforts at behavioral modification. The purpose of this trial was to test whether a single ketamine infusion improved treatment outcomes in cocaine-dependent adults engaged in mindfulness-based relapse prevention. METHODS: Fifty-five cocaine-dependent individuals were randomly assigned to receive a 40-minute intravenous infusion of ketamine (0.5 mg/kg) or midazolam (the control condition) during a 5-day inpatient stay, during which they also initiated a 5-week course of mindfulness-based relapse prevention. Cocaine use was assessed through self-report and urine toxicology. The primary outcomes were end-of-study abstinence and time to relapse (defined as first use or dropout). RESULTS: Overall, 48.2% of individuals in the ketamine group maintained abstinence over the last 2 weeks of the trial, compared with 10.7% in the midazolam group (intent-to-treat analysis). The ketamine group was 53% less likely (hazard ratio=0.47; 95% CI=0.24, 0.92) to relapse (dropout or use cocaine) compared with the midazolam group, and craving scores were 58.1% lower in the ketamine group throughout the trial (95% CI=18.6, 78.6); both differences were statistically significant. Infusions were well tolerated, and no participants were removed from the study as a result of adverse events. CONCLUSIONS: A single ketamine infusion improved a range of important treatment outcomes in cocaine-dependent adults engaged in mindfulness-based behavioral modification, including promoting abstinence, diminishing craving, and reducing risk of relapse. Further research is needed to replicate these promising results in a larger sample.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Dakwar E, Nunes EV, Hart CL, et al. A Single Ketamine Infusion Combined With Mindfulness-Based Behavioral Modification to Treat Cocaine Dependence: A Randomized Clinical Trial. Am J Psychiatry. 2019. PMID: 31230464. doi:10.1176/appi.ajp.2019.18101123

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。